Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: current position
Diana Álvarez,1,2 Melanie Levine,1 Mauricio Rojas1–3 1Dorothy P and Richard P Simmons Center for Interstitial Lung Disease, 2Pulmonary, Allergy, and Critical Care Medicine, 3McGowan Institute for Regenerative Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA...
Main Authors: | Álvarez D, Levine M, Rojas M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-04-01
|
Series: | Stem Cells and Cloning : Advances and Applications |
Online Access: | http://www.dovepress.com/regenerative-medicine-in-the-treatment-of-idiopathic-pulmonary-fibrosi-peer-reviewed-article-SCCAA |
Similar Items
-
Obstacles to early treatment of idiopathic pulmonary fibrosis: current perspectives
by: Moua T, et al.
Published: (2019-01-01) -
Review of current literature on the diagnosis and treatment of idiopathic pulmonary fibrosis
by: Burley, Sarah Victoria
Published: (2016) -
Idiopathic pulmonary fibrosis: The current state of the problem
by: E I Shmelev
Published: (2016-12-01) -
Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib
by: Bonella F, et al.
Published: (2015-12-01) -
Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives
by: Scott D. Collum, et al.
Published: (2017-01-01)